• Home
  • Search
  • Browse Collections
  • My Account
  • About
  • DC Network Digital Commons Network™
Skip to main content
Scholarly Commons University of the Pacific
  • Home
  • About
  • FAQ
  • My Account

Home > School of Pharmacy > Faculty Books and Book Chapters

School of Pharmacy Faculty Books and Book Chapters

 
A selection of published books and book chapters from faculty members of the Thomas J. Long School of Pharmacy at University of the Pacific.
Printing is not supported at the primary Gallery Thumbnail page. Please first navigate to a specific Image before printing.

Follow

Switch View to Grid View Slideshow
 
  • Life participation approaches to aphasia: international perspectives on communication rehabilitation by Larry Boles and Mimi Lewis

    Life participation approaches to aphasia: international perspectives on communication rehabilitation

    Larry Boles and Mimi Lewis

  • Rheumatoid arthritis by Eric G. Boyce

    Rheumatoid arthritis

    Eric G. Boyce

  • Fibromyalgia by Eric G. Boyce and B. H. Resman-Targoff

    Fibromyalgia

    Eric G. Boyce and B. H. Resman-Targoff

  • A guide for Doctor of Pharmacy program assessment by Eric G. Boyce

    A guide for Doctor of Pharmacy program assessment

    Eric G. Boyce

    Assessment activities in higher education are expanding from global institution-wide activities to include specific academic and student service program assessment as a means of improving programs. The assessment movement gained national impetus in the mid 1980s and has continued to expand due to the efforts of assessment experts, institutional and discipline accrediting agencies, professional associations, resource providers, and interested faculty and administrators. The American Association of Colleges of Pharmacy (AACP) has provided leadership and guidance for program assessment and student assessment in pharmacy education through the AACP CAPE Educational Outcomes document,[1] CAPE Handbook on Outcomes Assessment (1995),[2] Background Papers from the Commission to Implement Change in Pharmaceutical Education (1990-1992),[3] and numerous presentations at AACP Annual Meetings and the AACP Institute. The American Council on Pharmaceutical Education (ACPE) has also provided leadership and guidance for program assessment through the ACPE Accreditation Standards and Guidelines.[4-7] Colleges and schools of pharmacy have developed or are developing Pharm.D. program assessment plans and specific assessment methods. A guide and list of resources and examples of assessment plans, methods and tools would be useful to enhance program assessment at colleges and schools of pharmacy.

  • Appendices to the guide for Doctor of Pharmacy program assessment by Eric G. Boyce

    Appendices to the guide for Doctor of Pharmacy program assessment

    Eric G. Boyce

  • Rheumatoid arthritis and its therapy by Eric G. Boyce

    Rheumatoid arthritis and its therapy

    Eric G. Boyce

  • Rheumatoid arthritis cases by Eric G. Boyce

    Rheumatoid arthritis cases

    Eric G. Boyce

  • Rheumatoid Arthritis cases by Eric G. Boyce

    Rheumatoid Arthritis cases

    Eric G. Boyce

  • Rheumatoid arthritis and its therapy by Eric G. Boyce and Lawrence J. Leventhal

    Rheumatoid arthritis and its therapy

    Eric G. Boyce and Lawrence J. Leventhal

  • Pharmacology and acute toxicity of antirheumatic and immunologic therapy by Eric G. Boyce and Brian F. Mandell

    Pharmacology and acute toxicity of antirheumatic and immunologic therapy

    Eric G. Boyce and Brian F. Mandell

  • Hypoxia-selective cellular toxicity of carboranyl-nitroimidazole by John C. Livesey, L. W. Wiens, D. S. Wilbur, D. K. Hamlin, and G. E. Laramore

    Hypoxia-selective cellular toxicity of carboranyl-nitroimidazole

    John C. Livesey, L. W. Wiens, D. S. Wilbur, D. K. Hamlin, and G. E. Laramore

  • Physical Therapy (PT) and Touch and DRT by Kathryn C. Nesbit

    Physical Therapy (PT) and Touch and DRT

    Kathryn C. Nesbit

  • Preparation of meta-carboranyl-2-nitroimidazole derivatives for application to BNCT by D. S. Wilbur, D. K. Hamlin, John C. Livesey, R. R. Srivastava, G. E. Laramore, and T. W. Griffin

    Preparation of meta-carboranyl-2-nitroimidazole derivatives for application to BNCT

    D. S. Wilbur, D. K. Hamlin, John C. Livesey, R. R. Srivastava, G. E. Laramore, and T. W. Griffin

  • Rheumatoid arthritis by Eric G. Boyce

    Rheumatoid arthritis

    Eric G. Boyce

  • Rheumatoid arthritis cases by Eric G. Boyce

    Rheumatoid arthritis cases

    Eric G. Boyce

  • Boron neutron capture therapy: a means of increasing the effectiveness of fast neutron radiotherapy by G. E. Laramore, John C. Livesey, P. Wootton, D. S. Wilbur, J. Jacky, R. Risler, and R. Vessella

    Boron neutron capture therapy: a means of increasing the effectiveness of fast neutron radiotherapy

    G. E. Laramore, John C. Livesey, P. Wootton, D. S. Wilbur, J. Jacky, R. Risler, and R. Vessella

  • Boron neutron capture enhancement of the tumor dose in fast neutron therapy beams by P. Wootton, R. Risler, John C. Livesey, S. Brosard, G. E. Laramore, and T. W. Griffin

    Boron neutron capture enhancement of the tumor dose in fast neutron therapy beams

    P. Wootton, R. Risler, John C. Livesey, S. Brosard, G. E. Laramore, and T. W. Griffin

    The moderation of fast neutron beams by patients’ tissue, combined with developments in tumor affinic boron carriers,1 may allow supplementation of fast neutron beam therapy by boron neutron capture (BNC) reactions. This has the potential to enlarge the “radiation therapeutic window” in some types of tumors, e.g. prostate, and/or permit the development of such a window in the radiation response of others, e.g. brain. The work reported here extends from the studies made by others in fast neutron beams with average energies less than 10 MeV2,3 to beams with average energies up to 24 MeV such as are generated by the p(50.5 MeV) + Be(26MeV) reaction.

  • Chemical Protection Against Ionizing Radiation by John C. Livesey, Donald J. Reed, and Lucile F. Adamson

    Chemical Protection Against Ionizing Radiation

    John C. Livesey, Donald J. Reed, and Lucile F. Adamson

    The scientific literature on radiation-protective drugs is reviewed. Emphasis is placed on the mechanisms Involved in determining the sensitivity of biological material to ionizing radiation and mechanisms of chemical radioprotection. In Section 1, the types of radiation are described and the effects of ionizing radiation on biological systems are reviewed. The effects of ionizing radiation are briefly contrasted with the effects of non-Ionizing radiation. Section I reviews the contributions of various natural factors which influence the inherent radiosensitivity of biological systems. Included in the list of these factors are water, oxygen, thiols, vitamins and antioxidants. Brief attention is given to the model describing competition between oxygen and natural radioprotective substances (principally, thiols) In determining the net cellular radiosensitivity. Several theories of the mechanism(s) of action of radioprotective drugs are described In Section 111. These mechanisms include the production of hypoxia, detoxication of radiochemical reactive species, stabilization of the radiobiological target and the enhancement of damage repair processes. Section IV describes the current strategies for the treatment of radiation injury. Likely areas in which fruitful research might be performed are described in Section V. Appendices are devoted to lists of currently-funded research projects Involving chemical radiation protection and a brief compendium of compounds which have been tested for radioprotective activity.

  • Metabolism of 1,2-dihaloethanes by M. W. Anders and John C. Livesey

    Metabolism of 1,2-dihaloethanes

    M. W. Anders and John C. Livesey

 
  • 1
  • 2
  • 3
 
 

Search

Advanced Search

  • Notify me via email or RSS

Browse

  • Collections
  • Disciplines
  • Authors

Author Corner

  • Author FAQ

Links

  • Thomas J. Long School of Pharmacy website
University of the Pacific
 
Elsevier - Digital Commons

Home | About | FAQ | My Account | Accessibility Statement

Privacy Copyright